Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Immunogenic cell death and DAMPs in cancer therapy.

Krysko DV, Garg AD, Kaczmarek A, Krysko O, Agostinis P, Vandenabeele P.

Nat Rev Cancer. 2012 Dec;12(12):860-75. doi: 10.1038/nrc3380. Epub 2012 Nov 15. Review.

PMID:
23151605
2.

Many faces of DAMPs in cancer therapy.

Krysko O, Løve Aaes T, Bachert C, Vandenabeele P, Krysko DV.

Cell Death Dis. 2013 May 16;4:e631. doi: 10.1038/cddis.2013.156. Review.

3.

The PERKs of damage-associated molecular patterns mediating cancer immunogenicity: From sensor to the plasma membrane and beyond.

van Vliet AR, Martin S, Garg AD, Agostinis P.

Semin Cancer Biol. 2015 Aug;33:74-85. doi: 10.1016/j.semcancer.2015.03.010. Epub 2015 Apr 13. Review.

PMID:
25882379
4.

A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death.

Garg AD, Krysko DV, Verfaillie T, Kaczmarek A, Ferreira GB, Marysael T, Rubio N, Firczuk M, Mathieu C, Roebroek AJ, Annaert W, Golab J, de Witte P, Vandenabeele P, Agostinis P.

EMBO J. 2012 Mar 7;31(5):1062-79. doi: 10.1038/emboj.2011.497. Epub 2012 Jan 17.

5.

Multimodal immunogenic cancer cell death as a consequence of anticancer cytotoxic treatments.

Inoue H, Tani K.

Cell Death Differ. 2014 Jan;21(1):39-49. doi: 10.1038/cdd.2013.84. Epub 2013 Jul 5. Review.

6.

High hydrostatic pressure induces immunogenic cell death in human tumor cells.

Fucikova J, Moserova I, Truxova I, Hermanova I, Vancurova I, Partlova S, Fialova A, Sojka L, Cartron PF, Houska M, Rob L, Bartunkova J, Spisek R.

Int J Cancer. 2014 Sep 1;135(5):1165-77. doi: 10.1002/ijc.28766. Epub 2014 Feb 20.

7.

Wogonin induced calreticulin/annexin A1 exposure dictates the immunogenicity of cancer cells in a PERK/AKT dependent manner.

Yang Y, Li XJ, Chen Z, Zhu XX, Wang J, Zhang LB, Qiang L, Ma YJ, Li ZY, Guo QL, You QD.

PLoS One. 2012;7(12):e50811. doi: 10.1371/journal.pone.0050811. Epub 2012 Dec 12.

8.

Capsaicin as an inducer of damage-associated molecular patterns (DAMPs) of immunogenic cell death (ICD) in human bladder cancer cells.

D'Eliseo D, Manzi L, Velotti F.

Cell Stress Chaperones. 2013 Nov;18(6):801-8. doi: 10.1007/s12192-013-0422-2. Epub 2013 Apr 12.

10.

ROS-induced autophagy in cancer cells assists in evasion from determinants of immunogenic cell death.

Garg AD, Dudek AM, Ferreira GB, Verfaillie T, Vandenabeele P, Krysko DV, Mathieu C, Agostinis P.

Autophagy. 2013 Sep;9(9):1292-307. doi: 10.4161/auto.25399. Epub 2013 Jun 19.

PMID:
23800749
11.

Molecular characteristics of immunogenic cancer cell death.

Tesniere A, Panaretakis T, Kepp O, Apetoh L, Ghiringhelli F, Zitvogel L, Kroemer G.

Cell Death Differ. 2008 Jan;15(1):3-12. Epub 2007 Nov 16. Review.

12.

Rose Bengal acetate photodynamic therapy (RBAc-PDT) induces exposure and release of Damage-Associated Molecular Patterns (DAMPs) in human HeLa cells.

Panzarini E, Inguscio V, Fimia GM, Dini L.

PLoS One. 2014 Aug 20;9(8):e105778. doi: 10.1371/journal.pone.0105778. eCollection 2014 Aug 20.

13.

Immunogenic cell death: can it be exploited in PhotoDynamic Therapy for cancer?

Panzarini E, Inguscio V, Dini L.

Biomed Res Int. 2013;2013:482160. doi: 10.1155/2013/482160. Epub 2012 Dec 30. Review.

14.

Molecular mechanisms of ATP secretion during immunogenic cell death.

Martins I, Wang Y, Michaud M, Ma Y, Sukkurwala AQ, Shen S, Kepp O, Métivier D, Galluzzi L, Perfettini JL, Zitvogel L, Kroemer G.

Cell Death Differ. 2014 Jan;21(1):79-91. doi: 10.1038/cdd.2013.75. Epub 2013 Jul 12.

15.

Crosstalk between ER stress and immunogenic cell death.

Kepp O, Menger L, Vacchelli E, Locher C, Adjemian S, Yamazaki T, Martins I, Sukkurwala AQ, Michaud M, Senovilla L, Galluzzi L, Kroemer G, Zitvogel L.

Cytokine Growth Factor Rev. 2013 Aug;24(4):311-8. doi: 10.1016/j.cytogfr.2013.05.001. Epub 2013 Jun 17. Review.

PMID:
23787159
16.
17.

Danger signalling during cancer cell death: origins, plasticity and regulation.

Garg AD, Martin S, Golab J, Agostinis P.

Cell Death Differ. 2014 Jan;21(1):26-38. doi: 10.1038/cdd.2013.48. Epub 2013 May 17. Review.

18.

Complementary induction of immunogenic cell death by oncolytic parvovirus H-1PV and gemcitabine in pancreatic cancer.

Angelova AL, Grekova SP, Heller A, Kuhlmann O, Soyka E, Giese T, Aprahamian M, Bour G, Rüffer S, Cziepluch C, Daeffler L, Rommelaere J, Werner J, Raykov Z, Giese NA.

J Virol. 2014 May;88(10):5263-76. doi: 10.1128/JVI.03688-13. Epub 2014 Feb 26.

19.

Immunogenic cell death by oncolytic herpes simplex virus type 1 in squamous cell carcinoma cells.

Takasu A, Masui A, Hamada M, Imai T, Iwai S, Yura Y.

Cancer Gene Ther. 2016 Apr;23(4):107-13. doi: 10.1038/cgt.2016.8. Epub 2016 Mar 18.

PMID:
26987291
20.

Immunogenic cell death, DAMPs and anticancer therapeutics: an emerging amalgamation.

Garg AD, Nowis D, Golab J, Vandenabeele P, Krysko DV, Agostinis P.

Biochim Biophys Acta. 2010 Jan;1805(1):53-71. doi: 10.1016/j.bbcan.2009.08.003. Epub 2009 Aug 28. Review.

PMID:
19720113

Supplemental Content

Support Center